Hub : Traits :

Hearing difficulty/problems: Yes

38 significantly associated models · 20 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 45393277 46782409 1 1 2.5e-07 1.4e-06 0.3400 96 CCDC17
2 2 42753863 44149442 1 1 6.9e-08 1.7e-05 0.1850 90 ZFP36L2
3 5 72162264 73934274 4 7 2.9e-16 1.4e-19 NaN NaN ANKRA2 ARHGEF28 RGNEF UTP15
4 5 147825590 149338157 1 1 6.0e-08 2.1e-07 1.0000 100 ABLIM3
5 6 42611872 44034691 2 1 5.4e-13 1.3e-14 0.0067 88 ZNF318
6 8 140969818 142706843 1 1 7.3e-08 6.4e-08 0.0159 80 PTK2
7 10 75189586 76603535 1 1 9.0e-08 5.5e-06 0.4600 97 AP3M1
8 11 117732806 119353188 4 1 9.0e-11 3.0e-10 1.0000 100 DDX6
9 12 109295508 110704487 1 1 5.4e-08 3.1e-07 1.0000 100 MMAB
10 17 6469505 7863344 1 1 2.9e-07 1.2e-06 0.1440 91 CLDN7
11 18 52324675 52873317 1 1 9.4e-08 4.0e-08 0.0961 91 CCDC68
12 19 19391402 19892796 1 1 1.1e-07 3.2e-06 0.2010 92 YJEFN3
13 19 52150601 52657049 1 1 3.1e-07 1.4e-04 0.1910 88 ZNF649

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Bipolar Disorder or Schizophrenia 1.21 1 0 0.0 0.00 1.0e+00 YJEFN3
Depressed Affect (Nagel 2018) 2.15 4 0 0.0 0.52 4.8e-01 DDX6 MMAB PTK2 ZNF318
Intelligence (Savage-Jansen 2018) 0.68 1 0 0.0 0.00 1.0e+00 PTK2
Neuroticism (Nagel 2018) 2.69 3 1 2.2 0.00 1.0e+00 DDX6 MMAB ZNF318
Schizophrenia vs Biploar Disorder 2.30 1 0 0.0 0.00 1.0e+00 PTK2
Worry (Nagel 2018) 1.82 2 1 2.2 0.00 1.0e+00 MMAB ZNF318
Crohns Disease (2017) 1.21 1 0 0.0 0.00 1.0e+00 AP3M1
Irritable Bowel Disease (IBD) 1.16 2 0 0.0 0.00 1.0e+00 AP3M1 CCDC17
Ulcerative Colitis (UC) 0.87 1 0 0.0 0.00 1.0e+00 CCDC17
Reaction Time 1.53 2 0 0.0 0.00 1.0e+00 AP3M1 CLDN7
Breast Cancer 1.58 3 0 0.0 0.00 1.0e+00 CCDC17 CLDN7 YJEFN3
Age at First Birth 1.33 1 0 0.0 0.00 1.0e+00 PTK2
HDL Cholesterol 2.04 1 1 2.2 0.00 1.0e+00 MMAB
Rheumatoid Arthritis 1.77 1 0 0.0 0.00 1.0e+00 CCDC17
Schizophrenia (2014) 1.37 2 0 0.0 0.00 1.0e+00 YJEFN3 ZNF318
Type 2 Diabetes (T2D) (2012) 2.39 1 0 0.0 0.00 1.0e+00 CLDN7
Blood Eosinophil Count 1.05 6 1 2.2 -0.97 9.4e-04 AP3M1 CLDN7 DDX6 RGNEF YJEFN3 ZFP36L2
Blood Platelet Count 1.60 9 4 8.9 -0.16 6.8e-01 ABLIM3 AP3M1 CCDC17 CCDC68 DDX6 MMAB YJEFN3 ZFP36L2 ZNF318
Blood Red Count 1.47 4 1 2.2 0.86 1.4e-01 CCDC17 PTK2 YJEFN3 ZFP36L2
Blood White Count 0.96 5 0 0.0 0.00 1.0e+00 CCDC68 DDX6 PTK2 UTP15 ZNF649
Heel T-Score 1.11 4 2 4.4 -0.15 8.1e-01 ARHGEF28 DDX6 ZFP36L2 ZNF318
BMI 1.21 3 0 0.0 0.00 1.0e+00 CCDC17 MMAB ZNF318
Height 0.70 4 3 6.7 0.49 5.1e-01 CCDC17 CLDN7 YJEFN3 ZNF318
Waist Hip Ratio (WHR) 1.43 5 1 2.2 -0.12 8.5e-01 ABLIM3 CLDN7 PTK2 YJEFN3 ZNF318
Systolic Blood Pressure 2.74 4 3 6.7 -0.95 5.4e-02 AP3M1 CLDN7 MMAB ZNF318
Smoking Status 1.36 1 0 0.0 0.00 1.0e+00 PTK2
Allergy or Eczema 1.21 3 0 0.0 0.00 1.0e+00 CCDC17 CCDC68 MMAB
Cardiovascular Disease 2.52 4 2 4.4 -0.63 3.7e-01 AP3M1 RGNEF ZFP36L2 ZNF318
Hypothyroidism (self reported) 1.49 1 0 0.0 0.00 1.0e+00 PTK2
Type 2 Diabetes (T2D) (2018) 0.98 1 0 0.0 0.00 1.0e+00 YJEFN3
Lung FEV1/FVC ratio 1.32 3 0 0.0 0.00 1.0e+00 ABLIM3 CCDC17 CLDN7
Lung FVC 1.52 3 1 2.2 0.00 1.0e+00 ABLIM3 CLDN7 RGNEF
Neuroticism 2.32 3 1 2.2 0.00 1.0e+00 DDX6 MMAB ZNF318
Chronotype (morning person) 0.84 2 0 0.0 0.00 1.0e+00 MMAB ZNF318
Hair Pigment 0.18 3 0 0.0 -0.69 3.1e-01 ARHGEF28 UTP15 YJEFN3
Tanning 0.14 1 0 0.0 0.00 1.0e+00 ZFP36L2
Number of treatments/medications taken 2.33 2 0 0.0 0.00 1.0e+00 ZFP36L2 ZNF318
Sensitivity / hurt feelings 1.80 2 1 2.2 0.00 1.0e+00 DDX6 MMAB
Frequency of depressed mood in last 2 weeks 2.04 1 0 0.0 0.00 1.0e+00 PTK2
Systolic blood pressure, automated reading 2.07 3 1 2.2 0.00 1.0e+00 AP3M1 CLDN7 ZNF318
Diabetes (father) 1.89 1 0 0.0 0.00 1.0e+00 CLDN7
Impedance of leg (right) 1.36 3 1 2.2 0.00 1.0e+00 MMAB PTK2 ZNF318
Leg fat-free mass (left) 0.93 3 0 0.0 0.00 1.0e+00 DDX6 MMAB PTK2
Trunk fat percentage 0.83 1 0 0.0 0.00 1.0e+00 ZFP36L2
Townsend deprivation index at recruitment 1.95 2 0 0.0 0.00 1.0e+00 MMAB YJEFN3
Maternal smoking around birth 1.60 2 0 0.0 0.00 1.0e+00 CLDN7 MMAB
Fed-up feelings 2.23 2 0 0.0 0.00 1.0e+00 CLDN7 PTK2
Taking other prescription medications 1.64 1 0 0.0 0.00 1.0e+00 ZNF318
Age when periods started (menarche) 0.89 1 0 0.0 0.00 1.0e+00 MMAB
High blood pressure 3.10 5 1 2.2 -0.67 2.1e-01 AP3M1 PTK2 RGNEF ZFP36L2 ZNF318
Hayfever, allergic rhinitis or eczema 1.10 1 0 0.0 0.00 1.0e+00 CCDC68
Medication: Atenolol 1.73 1 0 0.0 0.00 1.0e+00 ZFP36L2
Sitting height 1.31 5 2 4.4 0.03 9.6e-01 CCDC17 DDX6 PTK2 YJEFN3 ZNF318
Chronic bronchitis/emphysema (father) 1.20 1 0 0.0 0.00 1.0e+00 PTK2
High blood pressure (mother) 2.07 2 0 0.0 0.00 1.0e+00 AP3M1 ZNF318
Body mass index (BMI) 1.04 2 0 0.0 0.00 1.0e+00 CCDC17 YJEFN3
Impedance of leg (left) 1.48 3 1 2.2 0.00 1.0e+00 MMAB PTK2 ZNF318
Leg predicted mass (left) 0.92 3 0 0.0 0.00 1.0e+00 DDX6 MMAB PTK2
Trunk fat mass 0.74 1 0 0.0 0.00 1.0e+00 ZFP36L2
Waist circumference 1.06 1 0 0.0 0.00 1.0e+00 CLDN7
Nervous feelings 1.34 1 0 0.0 0.00 1.0e+00 MMAB
Frequency of tenseness / restlessness in last 2 weeks 1.96 1 1 2.2 0.00 1.0e+00 MMAB
Hearing difficulty/problems with background noise 12.15 12 3 6.7 0.99 6.3e-12 ABLIM3 ANKRA2 AP3M1 ARHGEF28 CCDC68 DDX6 MMAB PTK2 RGNEF UTP15 ZFP36L2 ZNF318
Forced vital capacity (FVC) 1.73 5 1 2.2 -0.70 1.8e-01 ABLIM3 CLDN7 DDX6 RGNEF YJEFN3
Qualifications: None of the above 1.22 1 0 0.0 0.00 1.0e+00 PTK2
Mouth/teeth dental problems 2.35 2 0 0.0 0.00 1.0e+00 MMAB PTK2
Allergy 1.38 2 0 0.0 0.00 1.0e+00 CCDC17 MMAB
Diabetes (self-reported) 1.02 1 0 0.0 0.00 1.0e+00 YJEFN3
Neuroticism score 2.41 4 0 0.0 0.49 5.1e-01 DDX6 MMAB ZFP36L2 ZNF318
Weight 0.78 2 0 0.0 0.00 1.0e+00 DDX6 MMAB
Impedance of arm (right) 0.87 2 0 0.0 0.00 1.0e+00 PTK2 YJEFN3
Arm fat percentage (right) 0.98 3 0 0.0 0.00 1.0e+00 CCDC17 CLDN7 ZFP36L2
Trunk fat-free mass 0.81 3 0 0.0 0.00 1.0e+00 DDX6 MMAB PTK2
Hip circumference 1.01 2 0 0.0 0.00 1.0e+00 ABLIM3 MMAB
Father's age at death 1.57 1 0 0.0 0.00 1.0e+00 ZFP36L2
Worrier / anxious feelings 1.28 1 0 0.0 0.00 1.0e+00 MMAB
Frequency of tiredness / lethargy in last 2 weeks 2.85 2 1 2.2 0.00 1.0e+00 MMAB ZFP36L2
Falls in the last year 2.03 2 0 0.0 0.00 1.0e+00 MMAB PTK2
Forced expiratory volume in 1-second (FEV1) 1.32 3 1 2.2 0.00 1.0e+00 ABLIM3 CLDN7 DDX6
Mouth/teeth dental problems: Dentures 1.91 2 0 0.0 0.00 1.0e+00 ARHGEF28 PTK2
Forced expiratory volume in 1-second (FEV1), Best measure 1.32 1 0 0.0 0.00 1.0e+00 ABLIM3
Impedance of arm (left) 0.91 2 1 2.2 0.00 1.0e+00 PTK2 YJEFN3
Arm fat mass (right) 0.94 1 0 0.0 0.00 1.0e+00 MMAB
Trunk predicted mass 0.79 3 0 0.0 0.00 1.0e+00 DDX6 MMAB PTK2
Standing height 0.88 4 2 4.4 -0.06 9.4e-01 CCDC17 DDX6 YJEFN3 ZNF318
Tense / 'highly strung' 1.31 1 0 0.0 0.00 1.0e+00 DDX6
Birth weight of first child 2.68 1 1 2.2 0.00 1.0e+00 PTK2
Peak expiratory flow (PEF) 1.54 4 0 0.0 -0.59 4.1e-01 ABLIM3 CLDN7 MMAB RGNEF
Mouth/teeth dental problems: Bleeding gums 2.51 2 0 0.0 0.00 1.0e+00 MMAB YJEFN3
Medication: Paracetamol 2.35 3 1 2.2 0.00 1.0e+00 MMAB PTK2 ZFP36L2
Gout (self-reported) 1.55 1 0 0.0 0.00 1.0e+00 ZNF318
Hypothyroidism/myxoedema (self-reported) 1.66 2 0 0.0 0.00 1.0e+00 DDX6 PTK2
Medication: Amlodipine 2.22 2 0 0.0 0.00 1.0e+00 AP3M1 ZNF318
Birth weight 3.42 2 1 2.2 0.00 1.0e+00 CLDN7 PTK2
Forced vital capacity (FVC), Best measure 1.73 5 0 0.0 -0.67 2.2e-01 ABLIM3 CLDN7 DDX6 RGNEF YJEFN3
Body fat percentage 0.94 1 0 0.0 0.00 1.0e+00 ZFP36L2
Leg fat percentage (right) 1.25 3 0 0.0 0.00 1.0e+00 CCDC17 CLDN7 ZFP36L2
Arm fat-free mass (right) 0.66 1 0 0.0 0.00 1.0e+00 DDX6
Comparative body size at age 10 1.69 3 0 0.0 0.00 1.0e+00 ARHGEF28 YJEFN3 ZNF318
Worry too long after embarrassment 1.84 1 0 0.0 0.00 1.0e+00 MMAB
Wheeze or whistling in the chest in last year 1.73 2 0 0.0 0.00 1.0e+00 RGNEF ZNF318
Age at first live birth 1.22 1 0 0.0 0.00 1.0e+00 PTK2
Qualifications: College or University degree 1.53 2 1 2.2 0.00 1.0e+00 PTK2 ZNF649
Medication for pain relief, constipation, heartburn 2.19 2 0 0.0 0.00 1.0e+00 PTK2 ZFP36L2
Neck or shoulder pain in last month 1.76 1 0 0.0 0.00 1.0e+00 PTK2
Medication: Blood pressure 2.22 1 0 0.0 0.00 1.0e+00 CLDN7
Medication: Seretide 50 evohaler 2.31 2 0 0.0 0.00 1.0e+00 RGNEF UTP15
Mean time to correctly identify matches 1.92 3 0 0.0 0.00 1.0e+00 AP3M1 CLDN7 YJEFN3
Whole body fat mass 0.83 1 0 0.0 0.00 1.0e+00 ZFP36L2
Leg fat mass (right) 0.95 1 0 0.0 0.00 1.0e+00 ZFP36L2
Arm predicted mass (right) 0.64 1 0 0.0 0.00 1.0e+00 DDX6
Pulse rate, automated reading 1.52 3 0 0.0 0.00 1.0e+00 CCDC17 MMAB UTP15
Alcohol intake frequency. 0.75 1 0 0.0 0.00 1.0e+00 ZNF318
Comparative height size at age 10 0.62 1 0 0.0 0.00 1.0e+00 CCDC17
Number of full sisters 1.60 1 0 0.0 0.00 1.0e+00 AP3M1
Overall health rating 2.05 3 0 0.0 0.00 1.0e+00 PTK2 YJEFN3 ZFP36L2
Chest pain or discomfort 1.18 1 0 0.0 0.00 1.0e+00 CLDN7
Had major operations 1.13 1 0 0.0 0.00 1.0e+00 CCDC17
Medication: Aspirin 2.17 1 0 0.0 0.00 1.0e+00 ZFP36L2
Knee pain experienced in last month 1.92 2 0 0.0 0.00 1.0e+00 AP3M1 PTK2
Hypertension (Self-reported) 2.98 4 1 2.2 -0.65 3.5e-01 AP3M1 PTK2 ZFP36L2 ZNF318
Illnesses of father: Heart disease 1.16 1 0 0.0 0.00 1.0e+00 ZFP36L2
Forced expiratory volume in 1-second (FEV1), predicted 0.94 1 0 0.0 0.00 1.0e+00 YJEFN3
Whole body fat-free mass 0.81 3 0 0.0 0.00 1.0e+00 DDX6 MMAB PTK2
Leg fat-free mass (right) 0.93 3 0 0.0 0.00 1.0e+00 DDX6 MMAB PTK2
Arm fat percentage (left) 1.01 2 0 0.0 0.00 1.0e+00 CCDC17 ZFP36L2
Mood swings 2.62 2 1 2.2 0.00 1.0e+00 MMAB PTK2
Loneliness, isolation 1.71 1 0 0.0 0.00 1.0e+00 DDX6
Long-standing illness, disability or infirmity 1.73 1 0 0.0 0.00 1.0e+00 MMAB
Diabetes diagnosed by doctor 1.10 1 0 0.0 0.00 1.0e+00 YJEFN3
Friendships satisfaction 1.28 1 0 0.0 0.00 1.0e+00 ABLIM3
Medication for cholesterol 1.68 1 0 0.0 0.00 1.0e+00 ZNF318
Back pain experienced in last month 1.63 1 0 0.0 0.00 1.0e+00 PTK2
Mineral and other dietary supplements 1.05 1 0 0.0 0.00 1.0e+00 AP3M1
Osteoarthritis (self-reported) 1.86 2 0 0.0 0.00 1.0e+00 CCDC17 PTK2
Medication: Aspirin 2.03 1 0 0.0 0.00 1.0e+00 ZFP36L2
Illnesses of father: None of the above (group 1) 1.49 1 0 0.0 0.00 1.0e+00 AP3M1
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.31 2 0 0.0 0.00 1.0e+00 ABLIM3 RGNEF
Whole body water mass 0.84 3 0 0.0 0.00 1.0e+00 DDX6 MMAB PTK2
Leg predicted mass (right) 0.93 3 0 0.0 0.00 1.0e+00 DDX6 MMAB PTK2
Arm fat mass (left) 0.89 1 0 0.0 0.00 1.0e+00 ZFP36L2
Number of self-reported non-cancer illnesses 2.37 2 0 0.0 0.00 1.0e+00 ZFP36L2 ZNF318
Average weekly champagne plus white wine intake 1.50 1 0 0.0 0.00 1.0e+00 DDX6
Miserableness 1.81 1 0 0.0 0.00 1.0e+00 MMAB
Hearing aid user 10.37 6 3 6.7 0.97 5.9e-05 ANKRA2 ARHGEF28 CCDC68 PTK2 RGNEF UTP15
Financial situation satisfaction 1.62 1 0 0.0 0.00 1.0e+00 MMAB
Tinnitus: Yes, now most or all of the time 2.45 1 0 0.0 0.00 1.0e+00 ZNF318
Commuting to job workplace: Public transport 1.20 1 0 0.0 0.00 1.0e+00 DDX6
Medication: Blood pressure 3.01 3 1 2.2 0.00 1.0e+00 AP3M1 ZFP36L2 ZNF318
Medication: Bendroflumethiazide 1.71 1 0 0.0 0.00 1.0e+00 ZNF318
Medication: Paracetamol 2.05 2 0 0.0 0.00 1.0e+00 PTK2 ZFP36L2
Illnesses of father: High blood pressure 1.72 1 0 0.0 0.00 1.0e+00 AP3M1
Basal metabolic rate 0.79 2 0 0.0 0.00 1.0e+00 DDX6 MMAB
Leg fat percentage (left) 1.24 3 0 0.0 0.00 1.0e+00 CCDC17 CLDN7 ZFP36L2
Arm fat-free mass (left) 0.69 1 0 0.0 0.00 1.0e+00 DDX6
Irritability 2.20 3 0 0.0 0.00 1.0e+00 CLDN7 MMAB ZFP36L2
Commuting to job workplace: Cycle 2.42 1 0 0.0 0.00 1.0e+00 UTP15
Vascular/heart problems diagnosed by doctor 3.26 5 1 2.2 0.66 2.3e-01 AP3M1 PTK2 RGNEF ZFP36L2 ZNF318
Cholesterol lowering medication 1.15 1 0 0.0 0.00 1.0e+00 ZNF318
Pain experienced in last month 2.47 3 0 0.0 0.00 1.0e+00 MMAB PTK2 ZFP36L2
Alcohol drinker status: Previous 1.70 1 0 0.0 0.00 1.0e+00 PTK2
Impedance of whole body 1.20 4 1 2.2 0.13 8.7e-01 MMAB PTK2 YJEFN3 ZNF318
Leg fat mass (left) 0.90 1 0 0.0 0.00 1.0e+00 ZFP36L2
Arm predicted mass (left) 0.71 1 0 0.0 0.00 1.0e+00 DDX6

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 2 0.057 1.6
GTEx Adipose Visceral Omentum 1 0.049 1.6
GTEx Adrenal Gland 0 0.000 1.6
GTEx Artery Aorta 0 0.000 1.5
GTEx Artery Coronary 0 0.000 1.6
GTEx Artery Tibial 1 0.027 1.5
GTEx Brain Caudate basal ganglia 1 0.109 1.5
GTEx Brain Cerebellar Hemisphere 0 0.000 1.5
GTEx Brain Cerebellum 1 0.050 1.6
GTEx Brain Cortex 1 0.097 1.5
GTEx Brain Frontal Cortex BA9 0 0.000 1.6
GTEx Brain Hippocampus 0 0.000 1.4
GTEx Brain Hypothalamus 0 0.000 1.4
GTEx Brain Nucleus accumbens basal ganglia 0 0.000 1.5
GTEx Brain Putamen basal ganglia 0 0.000 1.5
GTEx Breast Mammary Tissue 1 0.051 1.6
GTEx Breast Mammary Tissue (Male) 0 0.000 1.5
GTEx Breast Mammary Tissue (Female) 0 0.000 1.5
GTEx Cells EBV-transformed lymphocytes 0 0.000 1.6
GTEx Cells Transformed fibroblasts 1 0.024 1.5
GTEx Colon Sigmoid 0 0.000 1.6
GTEx Colon Transverse 0 0.000 1.6
GTEx Esophagus Gastroesophageal Junction 0 0.000 1.5
GTEx Esophagus Mucosa 2 0.060 1.6
GTEx Esophagus Muscularis 0 0.000 1.6
GTEx Heart Atrial Appendage 0 0.000 1.5
GTEx Heart Left Ventricle 0 0.000 1.6
GTEx Liver 1 0.139 1.5
GTEx Lung 0 0.000 1.6
GTEx Muscle Skeletal 0 0.000 1.6
GTEx Nerve Tibial 1 0.023 1.6
GTEx Ovary 0 0.000 1.5
GTEx Pancreas 1 0.061 1.6
GTEx Pituitary 0 0.000 1.6
GTEx Prostate 0 0.000 1.5
GTEx Skin Not Sun Exposed Suprapubic 0 0.000 1.6
GTEx Skin Sun Exposed Lower leg 0 0.000 1.6
GTEx Small Intestine Terminal Ileum 0 0.000 1.5
GTEx Spleen 0 0.000 1.6
GTEx Stomach 0 0.000 1.5
GTEx Testis 0 0.000 1.6
GTEx Thyroid 0 0.000 1.7
GTEx Uterus 0 0.000 1.7
GTEx Vagina 0 0.000 1.4
GTEx Whole Blood 0 0.000 1.6
METSIM Adipose 1 0.022 1.5
NTR Blood 1 0.042 1.5
ROSMAP Brain Pre-frontal Cortex 2 0.046 1.6
YFS Blood 1 0.022 1.5
CommonMind Brain Pre-frontal Cortex 2 0.037 1.5
The Cancer Genome Atlas Bladder Urothelial Carcinoma 0 0.000 1.5
The Cancer Genome Atlas Breast Invasive Carcinoma 1 0.023 1.4
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 0 0.000 1.5
The Cancer Genome Atlas Colon Adenocarcinoma 0 0.000 1.5
The Cancer Genome Atlas Esophageal Carcinoma 0 0.000 1.6
The Cancer Genome Atlas Glioblastoma Multiforme 0 0.000 1.5
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 0 0.000 1.6
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 1 0.024 1.4
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 1 0.049 1.5
The Cancer Genome Atlas Brain Lower Grade Glioma 2 0.046 1.5
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 1 0.090 1.6
The Cancer Genome Atlas Lung Adenocarcinoma 2 0.068 1.5
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 0 0.000 1.5
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 1 0.063 1.6
The Cancer Genome Atlas Pancreatic Adenocarcinoma 0 0.000 1.6
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 1 0.075 1.6
The Cancer Genome Atlas Prostate Adenocarcinoma 3 0.065 1.5
The Cancer Genome Atlas Rectum Adenocarcinoma 1 0.145 1.5
The Cancer Genome Atlas Soft Tissue Sarcoma 1 0.094 1.6
The Cancer Genome Atlas Skin Cutaneous Melanoma 1 0.187 1.4
The Cancer Genome Atlas Stomach Adenocarcinoma 0 0.000 1.6
The Cancer Genome Atlas Testicular Germ Cell Tumors 0 0.000 1.5
The Cancer Genome Atlas Thyroid Carcinoma 1 0.019 1.5
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 0 0.000 1.5